CRISPR Therapeutics AG (CRSP) financial statements (2020 and earlier)

Company profile

Business Address BAARERSTRASSE 14
ZUG, CH-6300
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments944630428438457487320
Cash and cash equivalents944630428438457487320
Receivables0011012
Other undisclosed current assets443410121089
Total current assets:988664438450466497331
Noncurrent Assets
Operating lease, right-of-use asset4231  
Property, plant and equipment31212019191818
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Restricted cash and investments5443333
Other noncurrent assets1111111
Other undisclosed noncurrent assets  3125   
Total noncurrent assets:79575648232223
TOTAL ASSETS:1,067721494498489519353
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities37272623263117
Accounts payable6377554
Accrued liabilities30221916212613
Taxes payable1111000
Deferred revenue148  
Debt85     
Deferred rent credit    111
Other liabilities11 00000
Other undisclosed current liabilities  55   
Total current liabilities:57803128283218
Noncurrent Liabilities
Long-term debt and lease obligation4437     
Operating lease, liability4437  
Liabilities, other than long-term debt26125858696969
Deferred revenue1212  
Contract with customer, liability5858585858
Deferred rent credit    111111
Other liabilities14000000
Other undisclosed noncurrent liabilities  3732   
Total noncurrent liabilities:70499590696969
Total liabilities:1271291271189710288
Stockholders' equity
Stockholders' equity attributable to parent939592368380392417265
Common stock2222221
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital1,162846760718682660457
Accumulated other comprehensive income (loss)0(0)(0) (0)(0)0
Accumulated deficit(225)(255)(394)(340)(292)(244)(193)
Total stockholders' equity:939592368380392417265
TOTAL LIABILITIES AND EQUITY:1,067721494498489519353

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenue from related parties(212)21200 01
Gross profit:7721200011
Operating expenses(66)(73)(55)(49)(45)(50)(38)
Operating income (loss):11139(55)(48)(45)(49)(37)
Nonoperating income (expense)20(0)10(2)(1)(1)
Other nonoperating income (expense)20321(1)(0)0
Income (loss) from continuing operations before equity method investments, income taxes:31139(54)(48)(47)(51)(38)
Loss from equity method investments(5)   (4)  
Other undisclosed income from continuing operations before income taxes5   4  
Income (loss) from continuing operations before income taxes:31139(54)(48)(47)(51)(38)
Income tax expense(0)(0)(0)(0)(0)(0)(0)
Net income (loss) available to common stockholders, diluted:31138(54)(48)(48)(51)(38)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income (loss):31138(54)(48)(48)(51)(38)
Other comprehensive income   0   
Other undisclosed comprehensive loss    (0)  
Comprehensive income (loss):31138(54)(48)(48)(51)(38)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0) 0(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:31138(54)(48)(48)(51)(38)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: